COMMUNIQUÉS West-GlobeNewswire

L'essai clinique de Phase 2 sur le bermekimab montre une nouvelle norme de soins potentielle pour le traitement de l'hidrasadénite suppurée (HS), avec une réduction significative de la douleur sans associer d’antibiotiques
07/03/2019
- Avantage thérapeutique significatif obtenu, que les patients aient, ou non, déjà échoué au traitement avec un médicament biologique existant autorisé par la FDA. - 61 à 63 % des patients ont obtenu un score HiSCR [...]
ShockWave Announces Pricing of Initial Public Offering
07/03/2019
SANTA CLARA, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- ShockWave Medical, Inc. (“ShockWave”) today announced the pricing of its initial public offering of 5,700,000 shares of its common stock at a price to the public [...]
La collaboration entre Crown Bioscience et The Jackson Laboratory permet un accès mondial au modèle murin FATZO
07/03/2019
La collaboration continue facilite la distribution mondiale de l’obésité, des maladies métaboliques et du modèle NASH ainsi que l’approvisionnement prioritaire à la plateforme mondiale de maladies cardiovasculaires, de [...]
Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
BOSTON, March 06, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
MRI Interventions, Inc. to Announce Fourth Quarter and Full Year 2018 Results on March 11
06/03/2019
IRVINE, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed to deliver navigation, ablation, deep brain stimulation, biopsy and gene [...]
Innovative Cellular Therapeutics Announces Opening of U.S. Office and Appointment of New Members to Executive Leadership Team
06/03/2019
Accomplished Industry Leaders Join ICT to Spearhead U.S. Clinical Development Efforts ROCKVILLE, Md., March 06, 2019 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a biotechnology company developing [...]
Aptevo Announces Proposed Public Offering of Common Stock and Warrants
06/03/2019
SEATTLE, March 06, 2019 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology, autoimmune and hematology therapeutics, today announced that it intends [...]
Rockwell Medical, Inc. to Discuss Fourth Quarter and Full Year 2018 Financial Results on March 14, 2019
06/03/2019
WIXOM, Mich., March 06, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2018 fourth quarter and full year financial [...]
Idera Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update
06/03/2019
– ILLUMINATE-301 Enrollment on Track for Completion Q4 2019 – – ILLUMINATE-204 Enrollment Complete; Data Anticipated Q4 2019 – – ILLUMINATE-206 Trial Expected to Initiate Q2 2019 – – Chief Medical Officer Dr. Joanna [...]
INSYS Therapeutics to Report Fourth Quarter and Full Year 2018 Results on March 7
06/03/2019
PHOENIX, March 06, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]
Nephros to Report Fourth Quarter and Year End 2018 Financial Results on March 12th, 2019
06/03/2019
SOUTH ORANGE, NJ, March 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, [...]
Xeris Pharmaceuticals Announces Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline Progress
06/03/2019
Continuing to execute commercial build and launch readiness for Gvoke HypoPen™ Advancing pipeline of preclinical and clinical development-stage products Cash position of $112.6 million at year-end 2018; February 2019 [...]
Supernus to Present at the 2019 Cowen Health Care Conference
06/03/2019
ROCKVILLE, Md., March 06, 2019 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASADQ: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Adverum Biotechnologies Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update
06/03/2019
Advancing Novel Gene Therapy ADVM-022 for Wet AMD in OPTIC Phase 1 Clinical Trial MENLO PARK, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy [...]
Portola Pharmaceuticals to Webcast Presentation at Cowen and Company’s 39th Annual Health Care Conference
06/03/2019
SOUTH SAN FRANCISCO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that Scott Garland, Portola’s president and chief executive officer, will present a [...]
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
06/03/2019
TUSTIN, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update
06/03/2019
Pantheris Fourth Quarter Revenue Increases 18% Over Prior Quarter REDWOOD CITY, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and [...]
Teladoc Health to Participate in Upcoming Investor Conference
06/03/2019
PURCHASE, N.Y., March 06, 2019 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Jason Gorevic, chief executive officer, will participate in the following [...]
The Ensign Group Acquires Home Health and Hospice Operations in San Antonio, Texas
06/03/2019
MISSION VIEJO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care, [...]

Pages